The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
Arco Lab now holds a 50% stake in Neviton
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
AMI to become part of Enpro’s Sealing Technologies Segment
Marks remarkable acceleration in innovation using AI technology
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
NEIAFMR to be developed as the national hub for folk medicine
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes
Prior to joining Alembic, he was working with Lupin Limited for more than 11 years
Subscribe To Our Newsletter & Stay Updated
